11 August 2020
BiologicsCall for Editorial Board Members


Biologics
, a new journal published by MDPI, is looking for new Editorial Board Members with the passion to drive the journal forward in this exciting period of development. Biologics is dedicated to the publication of high-quality reviews, research papers, and communications in all areas of biologics derived from both novel and established biotechnologies. Please see the Biologics homepage for more information and details of the journal’s Aims & Scope.

This opportunity will allow you to keep up with research in our field and position yourself as one of the leaders in the evolving and exciting field of biologicals. Appointments to the Editorial Board are for a two-year period and may be renewable. As an EB member, you can publish one paper per year free of charge. Your name and affiliation will be displayed on the journal website.

The main responsibilities of Editorial Board Members are as follows:

  • Working closely with Editors to develop the journal’s vision, policy, and practices;
  • Pre-screening submissions and making decisions on whether a manuscript can be accepted or rejected for processing, and suggesting reviewers if necessary;
  • Acting as Guest Editor of a Special Issue in your particular field of expertise, or recommending potential topics and Guest Editors;
  • Promoting Biologics and increasing its visibility at related academic conferences;
  • Helping to solicit high quality papers for Biologics
  • Advising on the journal’s development.

The following are the criteria for the selection of board members:

  • A PhD degree and relevant expertise;
  • Having a strong interest in the scholarly journal;
  • Holding an appointment at a university, or an academic or research institution;
  • Prior experience in publishing in and reviewing for peer-review publications.

To apply or request further information, please send your curriculum vitae and a short statement of interest to the Biologics Editorial Office ([email protected]). We look forward to hearing from you.

Kind regards,
Biologics Editorial Office

Back to TopTop